Prevention of HIV/AIDS

United States HIV Infection Drug Market, Dosage, Price, Sales Insight Report 2021-2026 - ResearchAndMarkets.com

Retrieved on:

Monday, February 22, 2021

AIDS, Pharmaceutical, Health, Health sciences, Prevention of HIV/AIDS, Medicine, Health, Pharmacy, Pre-exposure prophylaxis, HIV/AIDS, Pharmaceutical industry, HIV/AIDS in Canada, William A. Haseltine

The "US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026" report has been added to ResearchAndMarkets.com's offering.
The research report prepared delivers insight for the US HIV drug market, which includes the growth areas as well as the channel perspective.
In the research report, the impacts of the novel drug launches are described over the traditional drugs.
Pharmaceutical opportunities in the US related with HIV drug market is observed to be growing subsequently with time.

Innovative Text Messaging Campaign Promotes Indigenous Youth Sexual Wellness

Retrieved on:

Thursday, February 18, 2021

Prevention of HIV/AIDS, Clinical medicine, Medicine, Medical specialties, Puberty, Sexual health, Barrier contraception, Female condom, Vagina, HIV/AIDS, Text messaging, Sexually transmitted infection

PORTLAND, Ore., Feb. 18, 2021 /PRNewswire/ --Healthy Native Youth (HNY)isproud to announce a collaborative effort to elevate adolescent sexual health for American Indian and Alaska Native (AI/AN) teens with the newly launched TalkingIsPowertext messaging campaign .

Key Points:

PORTLAND, Ore., Feb. 18, 2021 /PRNewswire/ --Healthy Native Youth (HNY)isproud to announce a collaborative effort to elevate adolescent sexual health for American Indian and Alaska Native (AI/AN) teens with the newly launched TalkingIsPowertext messaging campaign .
Funded by the Minority HIV/AIDS Fund (MHAF), the text messaging campaign text EMPOWERto 97779 -- provides a resource for AI/AN parents and caring adults to initiate difficult conversations about sexual health topics with their teens and young adults.
The text messaging platform ensures broad access in a time when many indigenous communities lack access to reliable internet.
Caring adults can text the word "EMPOWER" to 97779 to receive weekly text messages that include culturally appropriate tips and resources, covering sexual health, pregnancy, HIV/STDs, condoms, and consent.

European Syringe Collection and Analysis Enterprise (ESCAPE) – generic protocol

Retrieved on:

Thursday, February 18, 2021

Psychoactive drugs, Drug culture, Medical specialties, Harm reduction, Health, Addiction medicine, Drug paraphernalia, Prevention of HIV/AIDS, Needle and syringe programmes, Syringe, Injection, Heroin

This protocol documents a new approach that has been developed to monitor substances injected by people who inject drugs through analytically confirmed data at the local level: the analysis of residual content of used syringes.

Key Points:

This protocol documents a new approach that has been developed to monitor substances injected by people who inject drugs through analytically confirmed data at the local level: the analysis of residual content of used syringes.
Used syringes contain traces of drugs that can be analysed to inform public health professionals about injecting drug use, and to contribute to the understanding of drug addiction among people who inject drugs.
Used syringes can be collected from low-threshold services where needle exchange programmes are in place.
They can also be collected from automatic injection kit dispensers, combined with street bins (where people who inject drugs can obtain their new sterile injection kit in return of a used syringe), thereby obtaining injecting material from populations that might not be in contact with health and social services.

HIV Treatments: From Antiretroviral Therapy to Vaccines, Upcoming Webinar Hosted by Xtalks

Retrieved on:

Monday, February 15, 2021

Prevention of HIV/AIDS, Medical specialties, HIV/AIDS, Retroviridae, Health, Pandemics, HIV, HIV/AIDS research, Division of Acquired Immunodeficiency Syndrome

Despite the progress that has been made, elements including HIV disease heterogeneity and geographical variation pose challenges to HIV clinical trials.

Key Points:

Despite the progress that has been made, elements including HIV disease heterogeneity and geographical variation pose challenges to HIV clinical trials.
How can the drug development industry overcome these challenges to support the HIV community by advancing novel treatment options?
For more information, or to register for this event, visit HIV Treatments: From Antiretroviral Therapy to Vaccines.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community.

National Condom Month: Shirin Peters, M.D. Offers 3 Steps to Combat Rising STI Rates Amid National Supply Shortage of STI Testing Kits

Retrieved on:

Saturday, February 13, 2021

Other Consumer, Medical Supplies, Infectious diseases, Other Retail, Other Health, Health, Consumer, General Health, Retail, Sexual health, Prevention of HIV/AIDS, HIV/AIDS, Medical specialties, Barrier contraception, Female condom, Vagina, Condom, Human reproduction, Health

In addition, there is also a reported national supply shortage of STI test kits and lab supplies.

Key Points:

In addition, there is also a reported national supply shortage of STI test kits and lab supplies.
View the full release here: https://www.businesswire.com/news/home/20210213005018/en/
Steps to Combat STIs for National Condom Month from Bethany Medical Clinic NY.
Dr. Peters advises on the following to combat risk of acquiring and transmitting STIs:
Step One: Have the Talk.
Lets use National Condom Month to prioritize communication, protection, and early detection to reduce the spread of STIs, adds Dr. Peters.

China Condom Market Report 2021-2025 Featuring Qingdao London Durex, Wuhan Jissbon Sanitary Products, Guilin Latex, Double One Rubber, Shenyang Tiandi Latex, Double Butterfly, Okamoto & Daxiang

Retrieved on:

Thursday, February 11, 2021

British brands, Medical specialties, Condom, HIV/AIDS, Penis, Prevention of HIV/AIDS, Sexual health, Durex, Female condom, Human reproduction, Health

Apart from satisfying the domestic demand, condoms produced in China are largely exported to Hong Kong, South Africa, Russia, Britain, etc.

Key Points:

Apart from satisfying the domestic demand, condoms produced in China are largely exported to Hong Kong, South Africa, Russia, Britain, etc.
Condom brands can be classified into 3 categories in China market: Brands of the first category have production bases in China and manufacture their own products in China market, such as Durex, JISSBON, etc.
It is expected that the global and China condom market will continue to grow from 2021 to 2025.
2 Development Environment of China Condom Industry, 2020-2021
3 Status of China Condom Industry, 2015-2020
3.2 Demands for Condoms in China Market, 2015-2020
4 Analysis on Import and Export of Condoms in China, 2017-2020
5 Analysis on Sales Channels of Condoms in China, 2019-2021

China Condom Industry Report 2021: Import and Export 2017-2020 & Driving Forces and Market Opportunities 2021-2025 - ResearchAndMarkets.com

Retrieved on:

Wednesday, February 10, 2021

Retail, Other Retail, British brands, Medical specialties, Condom, HIV/AIDS, Penis, Prevention of HIV/AIDS, Sexual health, Durex, Female condom, Marketplace, Human reproduction, Health

Apart from satisfying the domestic demand, condoms produced in China are largely exported to Hong Kong, South Africa, Russia, Britain, etc.

Key Points:

Apart from satisfying the domestic demand, condoms produced in China are largely exported to Hong Kong, South Africa, Russia, Britain, etc.
Condom brands can be classified into 3 categories in China market: Brands of the first category have production bases in China and manufacture their own products in China market, such as Durex, JISSBON, etc.
It is expected that the global and China condom market will continue to grow from 2021 to 2025.
Driving Forces and Market Opportunities in China Condom Market, 2021-2025
Threats and Challenges in China Condom Market, 2021-2025
Prospect of China Condom Market, 2021-2025

International Condom Day: DKT International Highlights Importance of Condoms with Virtual and In-Person Activities Around the World

Retrieved on:

Monday, February 8, 2021

This year, International Condom Day serves as a great reminder to raise awareness about condoms and the benefits of using them.

Key Points:

This year, International Condom Day serves as a great reminder to raise awareness about condoms and the benefits of using them.
In Liberia, DKTs promotional efforts will raise awareness about not just the importance of condoms, but also healthy relationships and safe, consensual sex on university campuses.
For their 100,000 followers on Instagram, DKT will create an interactive story addressing all doubts and taboos about condoms as well as STI prevention.
Utilizing International Condom Day to raise awareness before Valentine's Day and Carnival, DKT will also create an educational video for social networks in other South American countries.

ViiV Healthcare receives Marketing Authorisation for Rukobia (fostemsavir), a first-in-class attachment inhibitor in combination with other antiretrovirals for the treatment of adults with multidrug-resistant HIV

Retrieved on:

Monday, February 8, 2021

However, for some people who are living with multidrug-resistant HIV, there is an urgent need for new treatment options.

Key Points:

However, for some people who are living with multidrug-resistant HIV, there is an urgent need for new treatment options.
The Marketing Authorisation for fostemsavir marks a significant milestone, as it addresses a critical unmet need in HIV care for those with little or no treatment options left.
At ViiV Healthcare, through our pioneering research and development, we aim to meet the diverse needs of the HIV community.
We wont stop until our research offers more ways to treat, and hopefully one day, cure HIV.

Gilead Sciences and Gritstone Announce Collaboration Utilizing Gritstone’s Vaccine Platform Technology for HIV Cure

Retrieved on:

Monday, February 1, 2021

Oncology, AIDS, Health, Infectious diseases, Hospitals, Pharmaceutical, Biotechnology, Biotechnology, Biology, Life sciences, Vaccines, HIV vaccine, HIV/AIDS, Hypothetical technology, Prevention of HIV/AIDS, Viral vector, Vaccine, Adenoviridae, Gilead Sciences

View the full release here: https://www.businesswire.com/news/home/20210201005208/en/

Key Points:

View the full release here: https://www.businesswire.com/news/home/20210201005208/en/
Gilead and Gritstone will develop an HIV-specific therapeutic vaccine using Gritstones proprietary prime-boost vaccine platform, comprised of self-amplifying mRNA (SAM) and adenoviral vectors, with antigens developed by Gilead.
Gritstones vaccine technology has the potential to educate the immune system to specifically recognize and destroy HIV-infected cells by leveraging SAM and adenoviral vectors.
Additionally, the company has a global collaboration for the development of a therapeutic HIV vaccine with Gilead Sciences.
All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements.